So why can’t you get good information about drugs?
Everybody who is working on these drugs and their safety is getting paid by Big Pharma.
But how long will they get paid by Big Pharma if they show bad results?
Now, drugs go through a certain cycle.
The beginning of the cycle is the miracle stage of the process.
During this stage, everything is perfect and wonderful.
All of the reports are covered in angel wings and halos.
There are a few little cracks in the matrix, but they’re tiny at this point.
Everyone ignores these tiny chinks easily because they’re so heavily discounted.
And nobody is studying the bad things.
Over about 15 or 20 years from the beginning, the bad effects start to add up.
And they start to add up pretty quickly.
Suddenly, the drug is being banned here and outlawed there.
We’ve “discovered” at last that the drug is really bad and dangerous.
The thing is, we knew it was dangerous 15 or 20 years ago — when the cycle began.
But you, you the diabetic, you the user, are the guinea pigs.
To get a drug approved, the company only has to show studies for over one year of results.
They don’t have to show how the drug will work in your body.
And they don’t have to know what the effects you might suffer over multiple years of use.
Those warnings on the label are often the result of scientific guesswork or based on results for other similar drugs.
So now with that, let us talk about the latest diabetic drug GLP-1 receptor agonists for diabetes.
These are drugs such as Byetta and Victoza.
What these drugs do is stimulate the existing beta cells in the pancreas to produce more insulin.
The result is often weight loss and lower blood sugar along with lower A1C readings.
Doctors look at these two things with diabetes — they think this is the key to treating it properly.
If a drug lowers your weight and helps lower your blood sugar and A1C, it is considered a success.
Patients and doctors are happy with this Victoza weight loss and think it’s doing great things.
Unfortunately, the be-all and end-all for diabetes seems to be blood sugar.
It can kill you over the long run, but if it lowers your blood sugar, it will get approved.
I’m not saying that Victoza will kill you.
We really don’t know that.
But we do know that it does lower blood sugar.
So it gets approved.
The only research that is done after that is to confirm how wonderful the drug is.
Big Pharma pays the peer-reviewed medical journals, so they only publish research that supports Big Pharma’s agenda.
So the reports keep their angel wings and halos, and any negative reports get buried and ignored.
And it’s all perfectly legal.
Is Victoza dangerous or is it really the miracle they think it is?
So let’s see if we can dig any dirt on Victoza (liraglutide) or if we can recommend it.
A lot of people taking it suffer Victoza side effects, such as severe heartburn.
And that is one sign among others that this drug is doing damage.
Of course, none of this shows up in the so-called safety studies that the drug companies do.
The actual papers on the safety study of liraglutide omitted some important information on side effects.
But don’t worry about it, a scientist with the initial JBB explains that it’s okay.
“The original article was supported by Novo Nordisk. JBB has been, since 2005, an investigator, consultant, or speaker for Amylin, Bayhill Therapeutics, BD Research Laboratories, Bristol-Myers Squibb, Dexcom, Eli Lilly, GlaxoSmithKline, Intekrin, Intuity Medical, Johnson & Johnson, MannKind, Medtronic, Merck, MicroIslet, Novartis, Novo Nordisk, Osiris, Pfizer, Roche, Sanofi -Aventis, Transition Therapeutics, and Wyeth. JBB is also a shareholder of Insulet and is an employee of Novo Nordisk.”
So you can really trust people like this because they’re not on the payroll of the drug companies or anything…
Oh, wait, they are actually on the drug company payroll.
Maybe we SHOULD question it in a little bit.
I would laugh, but this is too serious to laugh.
What really happens is that people take all these miracle medications but get sicker and sicker.
Rather than fixing their diabetes, they just end up taking very expensive medications.
And they don’t feel any better, and they don’t live any longer.
Let’s look at what really happens.
In theory, stimulating the beta cells to produce more insulin sounds like a good idea.
It’s helping the body to do what it is supposed to be doing on its own.
But instead, this study shows that the idea backfires and causes more damage.
By stimulating the beta cells to produce more insulin, eventually, the beta cells become very tired of producing insulin.
Then bad things happen.
It just doesn’t make sense to stimulate the poor little beta cells in the pancreas like crazy and expect them to just keep performing.
Prolonged daily liraglutide treatment in a humanized mouse model is associated with initial improvement in function that is followed by progressive deterioration over time.
These findings are consistent with the notion that ‘‘excessive’’ activation of an already-overworked beta cell under diabetic conditions during long-term treatment may lead to metabolic exhaustion.
Now you understand the problem with this drug.
So you can start to understand why there will be more and more bad effects that show up.
It is also not certain that the bad effects are reversible.
I wouldn’t take this drug myself.
I don’t care what I had to do, I would get my diabetes taken care of another way.
If you’re on this drug and you feel that this makes a difference to you, talk to your doctor about changing it.
This drug produces long-term changes in how your beta cells produce insulin, or if they do.
It also changes your glucose metabolism.
And this damage may not be reversible.
So these drugs are probably quite destructive.
Liraglutide Compromises Pancreatic β Cell Function in a Humanized Mouse Model